The IVIS® SpectrumCT preclinical in vivo imaging system expands upon the versatility of the IVIS Spectrum by offering 2D and 3D imaging capabilities but includes integrated low-dose microCT ideal for longitudinal studies. The system provides researchers with greater insights into complex biological systems by enabling simultaneous molecular and anatomical non-invasive imaging in animal models.
The constant horizontal gantry motion and the flat panel detector provide unparalleled performance for low-dose imaging and automated optical and microCT integration. The stable revolving animal platform table rotates 360° to acquire full 3D data. Multiple animals can be scanned simultaneously while maintaining an average dose per scan at about 13mGy, with a scanning and reconstruction time of less than a minute. Optical and microCT modalities can also operate independently.
Key features include:
The IVIS SpectrumCT is an integrative platform that combines the full suite of IVIS optical features including Spectral Unmixing, 2D and 3D quantitative bioluminescence and fluorescence with fast and low dose CT imaging. The simple user interface along with automated co-registration, advanced visualization and analysis tools are driven by Revvity’s market leading Living Image® software. The IVIS Spectrum CT enables longitudinal workflows to characterize disease progression and therapeutic effect throughout the complete experimental time frame with both quantitative CT and optical reconstructions. Fast imaging and the ability to image multiple animals offers the throughput required to scan large cohorts of animals quickly and draw sound conclusions from your experimental data.
Height |
206.0 cm
|
---|---|
Portable |
No
|
Width |
65.0 cm
|
Brand |
IVIS
|
---|---|
Imaging Modality |
microCT Imaging
Optical Imaging
|
Optical Imaging Classification |
Bioluminescence Imaging
Fluorescence Imaging
|
Quantity in a Package Amount |
1.0 each
|
Unit Size |
1 Unit
|
The ability to image protein-protein interactions (PPIs) in vivo has important implications for a wide variety of biological...
Adoptive cell transfer using chimeric antigen receptor (CAR-T) cell therapy in which the patient’s T-cells are extracted...
A large percentage of Type 2 diabetes mortality is related to cardiovascular complications. Consequently, there is a critical need...
Drug induced liver injury (DILI) is a major reason for late stage termination of drug discovery research projects, highlighting...
Aside from the traditional small-molecule chemotherapeutics or targeted therapy agents that have been widely used in the clinic...
The high heterogeneity, lack of tumor-specific targets, and immunosuppressive tumor microenvironment of solid tumors are all...
We are here to answer your questions.